KYTX Kyverna Therapeutics, Inc.: institutional ownership and insider trading
129 funds reported holding $380M of Kyverna Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $26.1M, with 31 new positions and 22 funds selling out; over the last 12 months insiders bought $2.00M and sold $293K on the open market.
Famous investors holding KYTX
- Izzy Englander (Millennium Management): $5.70M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.18M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.98M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.87M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $457K, 0.0% of the portfolio
Largest institutional holders of KYTX
- GordonMD Global Investments LP — $37.8M
- GILEAD SCIENCES, INC. (GILD) — $36.8M
- BlackRock, Inc. (BLK) — $27.9M
- Vida Ventures Advisors, LLC — $27.1M
- Bain Capital Life Sciences Investors, LLC — $25.7M
- AIGH Capital Management LLC — $24.9M
- DEERFIELD MANAGEMENT COMPANY, L.P. — $17.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $16.9M
- VANGUARD GROUP INC — $16.7M
- PRICE T ROWE ASSOCIATES INC /MD/ — $10.6M
Recent KYTX insider trades
- Dec 18, 2025: Seidenberg Beth C bought 133,333 shares ($1000K)
- Dec 18, 2025: Westlake BioPartners Fund I, L.P. bought 133,333 shares ($1000K)
- Dec 15, 2025: Walker Karen Marie sold 23,998 shares ($293K)
5%+ owners
- Orin Hirschman: 5.9% (Schedule 13G, filed Oct 19, 2026)
- BlackRock, Inc.: 5.1% (Schedule 13G, filed Jul 29, 2026)